Ayman Chit

3.3k total citations
88 papers, 2.0k citations indexed

About

Ayman Chit is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, Ayman Chit has authored 88 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Epidemiology, 29 papers in Health and 17 papers in Infectious Diseases. Recurrent topics in Ayman Chit's work include Influenza Virus Research Studies (48 papers), Respiratory viral infections research (26 papers) and Vaccine Coverage and Hesitancy (25 papers). Ayman Chit is often cited by papers focused on Influenza Virus Research Studies (48 papers), Respiratory viral infections research (26 papers) and Vaccine Coverage and Hesitancy (25 papers). Ayman Chit collaborates with scholars based in Canada, United States and France. Ayman Chit's co-authors include Edward W. Thommes, Robertus van Aalst, Jason K. H. Lee, David P. Greenberg, Salaheddin M. Mahmud, Andrea C. Tricco, Charlene Soobiah, Genevieve Meier, Chris T. Bauch and Harish Nair and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Ayman Chit

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ayman Chit Canada 24 1.4k 604 545 263 170 88 2.0k
Jennifer P. King United States 20 1.1k 0.7× 460 0.8× 420 0.8× 157 0.6× 148 0.9× 57 1.9k
Tyra Grove Krause Denmark 28 1.1k 0.8× 847 1.4× 648 1.2× 297 1.1× 291 1.7× 100 2.5k
Ruth Link‐Gelles United States 26 1.4k 0.9× 1.0k 1.7× 664 1.2× 274 1.0× 132 0.8× 73 2.5k
Francisco Averhoff United States 27 1.9k 1.3× 611 1.0× 522 1.0× 138 0.5× 95 0.6× 91 2.5k
Theresa Tam Canada 21 1.1k 0.8× 508 0.8× 268 0.5× 422 1.6× 84 0.5× 42 1.7k
Jessie R. Chung United States 22 1.6k 1.1× 551 0.9× 323 0.6× 234 0.9× 261 1.5× 56 1.9k
Sarah A. Buchan Canada 25 655 0.5× 1.3k 2.2× 504 0.9× 307 1.2× 83 0.5× 94 2.1k
Cornelius Remschmidt Germany 25 875 0.6× 451 0.7× 311 0.6× 165 0.6× 72 0.4× 41 1.5k
Fiona P. Havers United States 24 1.2k 0.8× 720 1.2× 408 0.7× 147 0.6× 74 0.4× 63 2.0k
Simon Cottrell United Kingdom 16 693 0.5× 837 1.4× 581 1.1× 389 1.5× 107 0.6× 43 1.6k

Countries citing papers authored by Ayman Chit

Since Specialization
Citations

This map shows the geographic impact of Ayman Chit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayman Chit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayman Chit more than expected).

Fields of papers citing papers by Ayman Chit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayman Chit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayman Chit. The network helps show where Ayman Chit may publish in the future.

Co-authorship network of co-authors of Ayman Chit

This figure shows the co-authorship network connecting the top 25 collaborators of Ayman Chit. A scholar is included among the top collaborators of Ayman Chit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayman Chit. Ayman Chit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kieffer, Alexia, Thomas Shin, Michael E. Greenberg, et al.. (2025). Comparison of the public health impact of RSV disease prevention options for infants: a static decision model of the US birth cohort. Expert Review of Vaccines. 24(1). 1086–1098.
4.
Yin, J. Kevin, Rebecca C. Harris, Matthew M. Loiacono, Ayman Chit, & Sandrine Samson. (2023). Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gärtner et al. Vaccine. 41(27). 3948–3948.
6.
Harris, Rebecca C., Yutao Chen, Pierre Côté, et al.. (2021). Impact of COVID-19 on routine immunisation in South-East Asia and Western Pacific: Disruptions and solutions. The Lancet Regional Health - Western Pacific. 10. 100140–100140. 57 indexed citations
7.
Bosco, Elliott, Kevin W. McConeghy, Patience Moyo, et al.. (2021). Geographic variation in influenza vaccination among U.S. nursing home residents: A national study. Journal of the American Geriatrics Society. 69(9). 2536–2547. 4 indexed citations
8.
Bardenheier, Barbara H., Rosa Baier, Stefan Gravenstein, et al.. (2020). Persistence of Racial Inequities in Receipt of Influenza Vaccination Among Nursing Home Residents in the United States. Clinical Infectious Diseases. 73(11). e4361–e4368. 7 indexed citations
9.
Okoli, George N., Olt Lam, Christiaan H. Righolt, et al.. (2020). Seasonal influenza vaccination in older people: A systematic review and meta-analysis of the determining factors. PLoS ONE. 15(6). e0234702–e0234702. 54 indexed citations
11.
Okoli, George N., Ahmed M Abou-Setta, Christine Neilson, et al.. (2019). Determinants of Seasonal Influenza Vaccine Uptake Among the Elderly in the United States: A Systematic Review and Meta-Analysis. SHILAP Revista de lepidopterología. 5. 3694948489–3694948489. 42 indexed citations
12.
Aalst, Robertus van, Stefan Gravenstein, Vincent Mor, et al.. (2019). Comparative effectiveness of high dose versus adjuvanted influenza vaccine: A retrospective cohort study. Vaccine. 38(2). 372–379. 44 indexed citations
13.
Lee, Jason K. H., Gary Lam, Thomas Shin, et al.. (2018). Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis. Expert Review of Vaccines. 17(5). 435–443. 108 indexed citations
14.
Delea, Thomas E., Derek Weycker, Mark Atwood, et al.. (2017). Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada. PLoS ONE. 12(5). e0175721–e0175721. 13 indexed citations
15.
Najafi, Mehdi, Marek Laskowski, Pieter T. de Boer, et al.. (2017). The Effect of Individual Movements and Interventions on the Spread of Influenza in Long-Term Care Facilities. Medical Decision Making. 37(8). 871–881. 20 indexed citations
16.
Boer, Pieter T. de, et al.. (2016). Cost-Effectiveness of Quadrivalent versus Trivalent Influenza Vaccine in the United States. Value in Health. 19(8). 964–975. 28 indexed citations
17.
Zhang, Shanshan, et al.. (2016). Cost of hospital management of Clostridium difficile infection in United States—a meta-analysis and modelling study. BMC Infectious Diseases. 16(1). 447–447. 220 indexed citations
18.
19.
Manson, Stephanie, et al.. (2013). Utility Mapping of the EORTC QLQ-C30 onto EQ-5D in Patients with Soft Tissue Sarcoma. Value in Health. 16(7). A419–A419. 2 indexed citations
20.
Chit, Ayman, et al.. (2013). Toward more specific and transparent research and development costs: The case of seasonal influenza vaccines. Vaccine. 32(26). 3336–3340. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026